3-iodo-alpha-methyltyrosine has been researched along with Anaplastic Ependymoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amthauer, H; Eisenacher, J; Felix, R; Gutberlet, M; Michel, R; Plotkin, M; Röttgen, R; Ruf, J; Stockhammer, F; Wurm, R; Wust, P | 1 |
1 other study(ies) available for 3-iodo-alpha-methyltyrosine and Anaplastic Ependymoma
Article | Year |
---|---|
Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Chordoma; Ependymoma; False Negative Reactions; False Positive Reactions; Female; Follow-Up Studies; Glioma; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Meningioma; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Pituitary Neoplasms; Radiopharmaceuticals; Retrospective Studies; Rhabdoid Tumor; Sensitivity and Specificity; Supratentorial Neoplasms; Tomography, Emission-Computed, Single-Photon | 2005 |